House orphan drug bill
Executive Summary
Rep. Studds (D-Mass.) and Energy & Commerce/Health subcommittee Chairman Waxman (D-Calif.) introduce companion legislation (HR 4959) on April 9 to Senate measure S 2060. Studds proposed a bill last year with a $150 mil. sales "trigger" for orphan drugs, after which FDA could consider marketing applications from competitors; changes in the new bill include adoption of S 2060's $200 mil. trigger....
Rep. Studds (D-Mass.) and Energy & Commerce/Health subcommittee
Chairman Waxman (D-Calif.) introduce companion legislation (HR
4959) on April 9 to Senate measure S 2060. Studds proposed a bill
last year with a $150 mil. sales "trigger" for orphan drugs, after
which FDA could consider marketing applications from competitors;
changes in the new bill include adoption of S 2060's $200 mil.
trigger.... |